Specialties

The FDA warned healthcare professionals that sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors.

Insulin, it turns out, may be as important for the mind as it is for the body. Research in the last few years has raised the possibility that Alzheimer’s memory loss could be due to a novel third form of diabetes.

Angiotensin-converting enzyme inhibitors that cross the blood-brain barrier slow mental decline by about 50% relative to the decline seen in patients on other antihypertensives, according to an observational study of 1,074 hypertensive subjects followed for a median of 6 years.

Researchers at Columbia University in New York have discovered that certain bone cells produce a hormone called osteocalcin, which influences beta-cell proliferation and controls the metabolism of blood sugar (glucose) and fat deposits through previously unknown mechanisms.

A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.

Dr. Sheri Colberg, author of The 7 Step Diabetes Fitness Plan: Living Well and Being Fit with Diabetes, has more help for your patients who need exercise. Exercising with Complications: Neuropathy. This is a good one to print out add to your handouts.

Patients with diabetes appear to be at a 3- to 4-fold increased risk of intracerebral hemorrhage (ICH) compared with patients without diabetes.

People consuming diets with a higher glycemic index than average were at greater risk of developing advanced age-related macular degeneration (AMD). The researchers suggest that 20 percent of cases of advanced AMD might have been prevented if individuals had consumed a diet with a glycemic index below average.

Painful neuropathy is more common in patients with type 2 diabetes than in those with type 1, due to metabolic syndrome, researchers suggest, because of a link with the metabolic syndrome.

A major epidemiological study conducted over eight years in Australia has shown that two classes of lipid-lowering drugs – statins and fibrates – significantly lower the risk of developing nerve damage known as peripheral sensory diabetic neuropathy.